Cocoon Biotech Inc. — Form D/A
Cocoon Biotech Inc. of Mansfield, MA, a company, filed a Form D amendment with the SEC on 2019-11-01. $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-11-01
- Form: D/A
- Accession: 0001611264-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $4.5M
- Minimum investment: $5K
- Investors: 32
- Date of first sale: 2017-02-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-281527
Issuer
- Name: Cocoon Biotech Inc.
- CIK: 0001611264
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 241 Francis Avenue, Mansfield, MA, 02048
- Phone: 617-356-7346
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Grace Colon | Director | NEWARK, CA |
| Annalisa Jenkins | Director | Dallas, TX |
| Mary Thistle | Director | CAMBRIDGE, MA |
| Charles Koppel | Director | Mansfield, MA |
| Ailis Tweed-Kent | Director | Mansfield, MA |
| Ailis Tweed-Kent | Executive Officer | Mansfield, MA |
Other filings by this issuer (5)
More